Clinical trial No longer in our active list Interventional Ages 20 to 65

Using LED light to treat skin discoloration

Official title: The Therapeutic and Preventive Effects of Light-emitting Diodes (LEDs) Irradiation for Post-inflammatory Erythema and Hyperpigmentation: a Self-controlled

Run by Huashan Hospital · NCT06349447 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests if LED light therapy can help reduce skin discoloration caused by inflammation in healthy adults aged 20-65.

Quick facts

Study typeInterventional
Ages20 Years to 65 Years
SexAll
Enrollment10 (estimated)
SponsorHuashan Hospital
Academic / other
Locations1 site (Shanghai)
Trial IDNCT06349447 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy Asian individuals aged 20-65 with Fitzpatrick skin types III-IV.

Probably not a fit

Patients with abnormal skin conditions, systemic diseases, or those who are pregnant or breastfeeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of 830 nm and 590 nm LED phototherapies in preventing and treating post-inflammatory erythema (PIE) and post-inflammatory hyperpigmentation (PIH). Healthy participants aged 20-65 with specific skin types will undergo LED treatments after inducing skin discoloration. The study will measure changes in skin conditions using various indices and photography over a 10-day follow-up period. The goal is to gather evidence on the efficacy of LED light therapy for these skin conditions.

Why it matters

Potential benefit: If successful, this treatment could provide a non-invasive option for patients suffering from skin discoloration due to inflammation.

How similar studies have gone: While evidence on LED efficacy for PIE and PIH is limited, similar photobiomodulation approaches have shown promise in other dermatological applications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Healthy Asians;
2. 20-65 years old;
3. Fitzpatrick classification III-IV;
4. Sign the informed consent form.

Exclusion Criteria:

1. Have abnormal skin manifestations, such as pigment diseases, photosensitivity diseases and other allergic diseases;
2. Those with a history of abnormal systemic diseases, such as heart disease, liver disease, kidney disease, tumors, and mental illness;
3. Women who are preparing for pregnancy, pregnant or breastfeeding;
4. Have used photosensitizing drugs within two weeks before inclusion in this study;
5. Topical or systemic drugs may be used during this study;
6. bad habits, such as smoking, drinking, etc.;
7. Volunteers who have recently participated in other clinical trials;

Where it's running

  • Huashan Hospital
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.